Timeline | Phase | Milestone |
---|---|---|
Following site approval -1 th | Set-up activity | - Training of local ePAMS+ Champion - Training of local ePAMS+ Implementation Team (comprising an AMS Lead; an antimicrobial pharmacist; a microbiologist and/or infection specialist; a medication safety officer; senior representatives from clinical areas impacted [including an acute/general consultant clinician who will act as an ePAMS+ Clinical Team lead]; a senior member of nursing staff; a specialty trainee doctor in year 3 or above; a core medical trainee; and a foundation doctor) - Ensure Cerner EPMA system is ready to go live with ePAMS+ tools on the implementation/’go live’ date - Extract of pre-intervention dataset from Cerner EPMA system |
Kick-off meeting preparation | - ePAMS+ champion and implementation team: finalise list of key members of clinical team - ePAMS+ champion and implementation team: organise and publicise kick-off meetings | |
-2 weeks | Kick-off and staff training | - ePAMS+ implementation team: organise completion of ePAMS+ online tool training by clinical staff within selected areas - ePAMS+ champion and implementation team: run kick-off meetings - ePAMS+ champion and implementation team: organise regular, supportive discussion meetings with clinical team within selected areas |
Week 1 | Implementation Go Live | - Activation/’go live’ of ePAMS+ intervention within Cerner EPMA |
Week 2+ | Implementation and data extraction | Monitoring and regular discussion of the implementation - Monthly extract of interim de-identified dataset from Cerner EPMA system - Fidelity Index development- ePAMS+ champion and implementation team: undertake data collection on implementation of ePAMS+ -All staff: undertake regular, supportive discussion of the implementation of ePAMS+ (based on the latest monitoring data). |
Week 16 | Assessment of long-term sustainability | - Extract and analysis of final dataset from Cerner EPMA system - Fidelity Index completion - analysis of feasibility trial results and development of full-scale trial protocol |